Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 408Rectal Neoplasms 152Colonic Neoplasms 150Pancreatic Neoplasms 114Stomach Neoplasms 110Neoplasm Metastasis 70Esophageal Neoplasms 60Esophageal Squamous Cell Carcinoma 33Neoplasms 31Adenocarcinoma Of Esophagus 27Gastrointestinal Neoplasms 17Cholangiocarcinoma 14Biliary Tract Neoplasms 14Gallbladder Neoplasms 12Carcinoma, Hepatocellular 12Adenocarcinoma 12Colorectal Cancer Metastatic 11Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 11Liver Neoplasms 10Digestive System Neoplasms 10Ovarian Neoplasms 9Small Cell Lung Carcinoma 8Locally Advanced Rectal Cancer 8Intestinal Neoplasms 8Bile Duct Neoplasms 8Carcinoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Digestive System Diseases 6Appendiceal Neoplasms 6

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3selpercatinib 2repotrectinib 1pralsetinib 1napabucasin 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1Sunitinib 1Octreotide 1Ocoxin 1Lutetium-177 1Lutetium 1Irinotecan 1Cisplatin 1Capecitabine 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endocrine System Diseases × Irinotecan × Gastrointestinal × Clear all
NCT03535727 2024-12-31

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
48 enrolled 24 charts
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡